Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)

RecruitingOBSERVATIONAL
Enrollment

3,200

Participants

Timeline

Start Date

December 9, 2016

Primary Completion Date

August 31, 2031

Study Completion Date

September 30, 2032

Conditions
NOMIDDIRANLRC4-MASSAVICANDLE
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH